je.st
news
Drugmaker AstraZeneca forecasts faster return to growth
2014-01-14 17:58:07| Biotech - Topix.net
AstraZeneca expects new drugs and a recent diabetes deal to offset a wave of patent expiries and return it to growth faster than analysts predict, with 2017 revenue likely to be broadly in line with the 2013 level.
Tags: return
growth
faster
forecasts
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||